Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI

Background Studies demonstrated sex differences in outcomes following acute myocardial infarction, with women more likely to develop heart failure (HF). Sacubitril/valsartan has been shown to reduce cardiovascular death and HF hospitalizations in patients with HF with reduced ejection fraction. Meth...

Full description

Bibliographic Details
Main Authors: Xiaowen Wang, Karola S. Jering, Maja Cikes, Mariya P. Tokmakova, Roxana Mehran, Yaling Han, Cara East, Freny Vaghaiwalla Mody, Yi Wang, Eldrin F. Lewis, Brian Claggett, John J. V. McMurray, Christopher B. Granger, Marc A. Pfeffer, Scott D. Solomon
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028942
_version_ 1797689828825890816
author Xiaowen Wang
Karola S. Jering
Maja Cikes
Mariya P. Tokmakova
Roxana Mehran
Yaling Han
Cara East
Freny Vaghaiwalla Mody
Yi Wang
Eldrin F. Lewis
Brian Claggett
John J. V. McMurray
Christopher B. Granger
Marc A. Pfeffer
Scott D. Solomon
author_facet Xiaowen Wang
Karola S. Jering
Maja Cikes
Mariya P. Tokmakova
Roxana Mehran
Yaling Han
Cara East
Freny Vaghaiwalla Mody
Yi Wang
Eldrin F. Lewis
Brian Claggett
John J. V. McMurray
Christopher B. Granger
Marc A. Pfeffer
Scott D. Solomon
author_sort Xiaowen Wang
collection DOAJ
description Background Studies demonstrated sex differences in outcomes following acute myocardial infarction, with women more likely to develop heart failure (HF). Sacubitril/valsartan has been shown to reduce cardiovascular death and HF hospitalizations in patients with HF with reduced ejection fraction. Methods and Results A total of 5661 patients (1363 women [24%]) with acute myocardial infarction complicated by reduced left ventricular ejection fraction (≤40%), pulmonary congestion, or both and ≥1 of 8 risk‐augmenting factors were randomized to receive sacubitril/valsartan or ramipril. The primary outcome was cardiovascular death or incident HF. Baseline characteristics, clinical outcomes, and safety events were compared according to sex, a prespecified subgroup. Female participants were older and had more comorbidities. After multivariable adjustment, women and men were at similar risks for cardiovascular death or all‐cause death. Women were more likely to have first HF hospitalization (hazard ratio [HR], 1.34 [95% CI, 1.05–1.70]; P=0.02) and total HF hospitalizations (HR, 1.39 [95% CI, 1.05–1.84]; P=0.02). Sex did not significantly modify the treatment effect of sacubitril/valsartan compared with ramipril on the primary outcome (P for interaction=0.11). Conclusions In contemporary patients who presented with reduced left ventricular ejection fraction, pulmonary congestion, or both, following acute myocardial infarction, women had a higher incidence of HF during follow‐up. Sex did not modify the treatment effect of sacubitril/valsartan relative to ramipril. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02924727.
first_indexed 2024-03-12T01:51:14Z
format Article
id doaj.art-5ee5a7d91baf43b3ab7f5ef485186e33
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-12T01:51:14Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-5ee5a7d91baf43b3ab7f5ef485186e332023-09-08T12:39:35ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-09-01121710.1161/JAHA.122.028942Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MIXiaowen Wang0Karola S. Jering1Maja Cikes2Mariya P. Tokmakova3Roxana Mehran4Yaling Han5Cara East6Freny Vaghaiwalla Mody7Yi Wang8Eldrin F. Lewis9Brian Claggett10John J. V. McMurray11Christopher B. Granger12Marc A. Pfeffer13Scott D. Solomon14Brigham and Women’s Hospital Harvard Medical School Boston MABrigham and Women’s Hospital Harvard Medical School Boston MAUniversity Hospital Centre Zagreb Zagreb CroatiaUniversity Multiprofile Hospital for Active Treatment Sv. Georgi Medical University Plovdiv Plovdiv BulgariaMount Sinai School of Medicine New York NYGeneral Hospital of Northern Theater Command Shenyang ChinaTexas Heart Center Dallas TXDavid Geffen School of Medicine at University of California, Los Angeles Veterans Affairs Greater Los Angeles Healthcare System Los Angeles CANovartis Pharmaceuticals Corporation East Hanover NJStanford University School of Medicine Palo Alto CABrigham and Women’s Hospital Harvard Medical School Boston MABritish Heart Foundation Glasgow Cardiovascular Research Centre University of Glasgow Glasgow Scotland United KingdomDuke University School of Medicine Durham NCBrigham and Women’s Hospital Harvard Medical School Boston MABrigham and Women’s Hospital Harvard Medical School Boston MABackground Studies demonstrated sex differences in outcomes following acute myocardial infarction, with women more likely to develop heart failure (HF). Sacubitril/valsartan has been shown to reduce cardiovascular death and HF hospitalizations in patients with HF with reduced ejection fraction. Methods and Results A total of 5661 patients (1363 women [24%]) with acute myocardial infarction complicated by reduced left ventricular ejection fraction (≤40%), pulmonary congestion, or both and ≥1 of 8 risk‐augmenting factors were randomized to receive sacubitril/valsartan or ramipril. The primary outcome was cardiovascular death or incident HF. Baseline characteristics, clinical outcomes, and safety events were compared according to sex, a prespecified subgroup. Female participants were older and had more comorbidities. After multivariable adjustment, women and men were at similar risks for cardiovascular death or all‐cause death. Women were more likely to have first HF hospitalization (hazard ratio [HR], 1.34 [95% CI, 1.05–1.70]; P=0.02) and total HF hospitalizations (HR, 1.39 [95% CI, 1.05–1.84]; P=0.02). Sex did not significantly modify the treatment effect of sacubitril/valsartan compared with ramipril on the primary outcome (P for interaction=0.11). Conclusions In contemporary patients who presented with reduced left ventricular ejection fraction, pulmonary congestion, or both, following acute myocardial infarction, women had a higher incidence of HF during follow‐up. Sex did not modify the treatment effect of sacubitril/valsartan relative to ramipril. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02924727.https://www.ahajournals.org/doi/10.1161/JAHA.122.028942heart failuremyocardial infarctionsacubitril/valsartansex differences
spellingShingle Xiaowen Wang
Karola S. Jering
Maja Cikes
Mariya P. Tokmakova
Roxana Mehran
Yaling Han
Cara East
Freny Vaghaiwalla Mody
Yi Wang
Eldrin F. Lewis
Brian Claggett
John J. V. McMurray
Christopher B. Granger
Marc A. Pfeffer
Scott D. Solomon
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
heart failure
myocardial infarction
sacubitril/valsartan
sex differences
title Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
title_full Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
title_fullStr Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
title_full_unstemmed Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
title_short Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
title_sort sex differences in clinical characteristics and outcomes after myocardial infarction with low ejection fraction insights from paradise mi
topic heart failure
myocardial infarction
sacubitril/valsartan
sex differences
url https://www.ahajournals.org/doi/10.1161/JAHA.122.028942
work_keys_str_mv AT xiaowenwang sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT karolasjering sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT majacikes sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT mariyaptokmakova sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT roxanamehran sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT yalinghan sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT caraeast sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT frenyvaghaiwallamody sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT yiwang sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT eldrinflewis sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT brianclaggett sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT johnjvmcmurray sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT christopherbgranger sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT marcapfeffer sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi
AT scottdsolomon sexdifferencesinclinicalcharacteristicsandoutcomesaftermyocardialinfarctionwithlowejectionfractioninsightsfromparadisemi